Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 11, 2019
Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancerSandeep Appunni, Vivek Anand, Madhuram Khandelwal, et al.Urology|March 25, 2017
Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell CancerSiddharth Yadav, Madhuram Khandelwal, Amlesh Seth, et al.Molecular and Cellular Biochemistry|June 28, 2021
Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significanceSandeep Appunni, Muni Rubens, Venkataraghavan Ramamoorthy, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 2, 2017
Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladderSandeep Appunni, Vivek Anand, Madhuram Khandelwal, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2025
RASSF1A and its epigenetic dysregulation in genitourinary cancer: a current updateSandeep Appunni, Vivek Anand, Madhuram Khandelwal, et al.Molecular and Cellular Biochemistry|January 26, 2018
Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1AMadhuram Khandelwal, Vivek Anand, Sandeep Appunni, et al.Molecular and Cellular Biochemistry|November 23, 2019
RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic targetMadhuram Khandelwal, Vivek Anand, Sandeep Appunni, et al.Journal of Cancer Research and Clinical Oncology|September 19, 2019
CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approachVivek Anand, Madhuram Khandelwal, Sandeep Appunni, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2020
Lumican, pro-tumorigenic or anti-tumorigenic: A conundrumSandeep Appunni, Muni Rubens, Venkataraghavan Ramamoorthy, et al.Pageof 1